Pages that link to "Q43811874"
Jump to navigation
Jump to search
The following pages link to Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension (Q43811874):
Displaying 50 items.
- Tai Chi for hypertension (Q24236754) (← links)
- Benefits and side effects of blood pressure lowering treatment: what was wrong with doxazosin in the ALLHAT? (Q24799267) (← links)
- (Q24806038) (← links)
- A clinical perspective of obesity, metabolic syndrome and cardiovascular disease (Q26753121) (← links)
- Risk factors for recurrent hypoglycemia in hospitalized diabetic patients admitted for severe hypoglycemia. (Q33781944) (← links)
- Microalbuminuria in essential hypertension: significance, pathophysiology, and therapeutic implications (Q33786866) (← links)
- Management of patients with hypertension and diabetes mellitus: advances in the evidence for intensive treatment (Q33867408) (← links)
- Insulin attenuates agonist-mediated calcium mobilization in cultured rat vascular smooth muscle cells (Q33901071) (← links)
- Insulin attenuates vasopressin-induced calcium transients and a voltage-dependent calcium response in rat vascular smooth muscle cells (Q34204591) (← links)
- A comparison of the prevalence and risk factors of high blood pressure among Japanese living in Japan, Hawaii, and Los Angeles. (Q34404188) (← links)
- Hyperglycemic crises in diabetes mellitus type 2. (Q34451755) (← links)
- Insulin resistance and cardiovascular risk in the pediatric patient (Q34513832) (← links)
- Thiazide diuretic prophylaxis for kidney stones and the risk of diabetes mellitus. (Q34615244) (← links)
- Insulin resistance and upper-normal glucose levels in hypertension: a review (Q34622256) (← links)
- Syndrome X and diabetes: what is the mystery? (Q35023955) (← links)
- Choosing the Correct Drug for the Individual Hypertensive Patient (Q35166889) (← links)
- Insulin resistance in offspring of hypertensive parents (Q35214297) (← links)
- Genetic and environmental architecture of the features of the insulin-resistance syndrome (Q35239129) (← links)
- Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system (Q35933720) (← links)
- Type II Diabetes and Syndrome X: Pathogenesis and Glycemic Management (Q36240014) (← links)
- Insulin Resistance, Hyperinsulinemia, Dyslipidemia, Hypertension, and Accelerated Atherosclerosis (Q36339952) (← links)
- Hypertension, coronary artery disease and insulin resistance-linked disorders with an impact on treatment (Q36362795) (← links)
- Metabolic considerations in the choice of therapy for the patient with hypertension (Q36482909) (← links)
- Insulin resistance and hypertension--implications for treatment (Q36682296) (← links)
- The chronic cardiovascular risk factor syndrome (syndrome X): mechanisms and implications for atherogenesis (Q36682346) (← links)
- Insulin resistance syndrome as a feature of cardiological syndrome X in non-obese men (Q36811174) (← links)
- Relevance of hemostatic risk factors on coronary morphology in patients with diabetes mellitus type 2 (Q37207656) (← links)
- Gender differences relating to metabolic syndrome and proinflammation in Finnish subjects with elevated blood pressure (Q37314634) (← links)
- Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insulin-like growth factor type I: implications for vascular disease in hyperinsulinemic states (Q37617131) (← links)
- Primary and Secondary Prevention Strategy for Cardiovascular Disease in Diabetes Mellitus (Q37831664) (← links)
- Suppressed expression of insulin‐like growth factor binding protein‐1 mRNA in the endometrium: A molecular mechanism associating endometrial cancer with its risk factors (Q38303231) (← links)
- Chronic inhibition of 11 β -hydroxysteroid dehydrogenase type 1 activity decreases hypertension, insulin resistance, and hypertriglyceridemia in metabolic syndrome (Q39469007) (← links)
- Glucose-induced alterations of cytosolic free calcium in cultured rat tail artery vascular smooth muscle cells (Q40342156) (← links)
- Controversies surrounding the treatment of the hypertensive patient with diabetes (Q40748755) (← links)
- Insulin resistance and risk factors for coronary heart disease (Q40812885) (← links)
- Nephropathy and hypertension in diabetes (Q40846304) (← links)
- Comparison of type 1 angiotensin II receptor blockers and angiotensin converting enzyme inhibitors in the treatment of hypertension (Q40867699) (← links)
- Evaluation of elevated blood pressure. (Q40891573) (← links)
- Essential hypertension in blacks: is it a metabolic disorder? (Q40893440) (← links)
- The evolving paradigm of hypertension. (Q40948143) (← links)
- Hyperinsulinaemia is not linked with blood pressure elevation in patients with insulinoma (Q41129178) (← links)
- Therapeutic challenges in the obese diabetic patient with hypertension (Q41171807) (← links)
- Metabolic manifestations of low-dose diuretics (Q41171832) (← links)
- Antihypertensive effects of vanadium compounds in hyperinsulinemic, hypertensive rats (Q41223351) (← links)
- Determinants of coronary vascular disease in patients with type II diabetes mellitus and their therapeutic implications. (Q41457652) (← links)
- Soluble Fiber and Hypertension (Q41636989) (← links)
- Normal insulin receptor tyrosine kinase activity and glucose transporter (GLUT 4) levels in the skeletal muscle of hyperinsulinaemic hypertensive rats (Q42006870) (← links)
- Hemostatic risk factors in patients with coronary artery disease and type 2 diabetes - a two year follow-up of 243 patients (Q42554965) (← links)
- Lercanidipine effect on polymorphonuclear leukocyte-related inflammation and insulin resistance in essential hypertension patients (Q42744261) (← links)
- Early left ventricular mechanics abnormalities in prehypertension: a two-dimensional strain echocardiography study (Q43203700) (← links)